Joseph Sarret

Company: CohBar

Job title: President & Chief Executive Officer

Seminars:

Mitochondrial Derived Peptides as a Source for Novel Therapeutics 2:00 pm

Analyzing how the effects of some mitochondrially encoded peptides are not limited to local regulation, but have important roles to play in critical biological pathways Exploring CB4211, a novel analog of MOTS-c being developed for the treatment of NASH and obesity, including positive clinical data from a multi-center, randomized, double blind placebo-controlled trial Examining how…Read more

day: Day One